Milestone Pharmaceuticals Ownership | Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals Ownership Summary

Milestone Pharmaceuticals is owned by 17.82% institutional investors, 4.71% insiders, and 77.47% retail investors. Blackrock is the largest institutional shareholder, holding 9.91% of MIST shares. Simplify Propel Opportunities ETF is the top mutual fund, with 1.59% of its assets in Milestone Pharmaceuticals shares.

MIST Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Milestone Pharmaceuticals	17.82%	4.71%	77.47%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	4.97M	9.91%	$6.56M
Millennium management	2.70M	4.08%	$6.38M
Alta fundamental advisers	2.66M	4.02%	$6.27M
Rtw investments, lp	2.51M	3.79%	$5.91M
Bleichroeder lp	1.33M	2.00%	$3.13M
Bml capital management	1.14M	1.72%	$2.68M
Morgan stanley	828.65K	1.65%	$1.09M
Lion point capital, lp	1.03M	1.55%	$2.42M
Toronto dominion bank	750.00K	1.13%	$1.77M
Stonepine capital management	500.00K	0.76%	$1.18M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lion point capital, lp	1.03M	12.68%	$2.42M
Alta fundamental advisers	2.66M	1.88%	$6.27M
Bml capital management	1.14M	1.67%	$2.68M
Stonepine capital management	500.00K	0.95%	$1.18M
Bleichroeder lp	1.33M	0.79%	$3.13M
Rtw investments, lp	2.51M	0.09%	$5.91M
Boxer capital	309.01K	0.02%	$407.89K
Beta wealth group	14.13K	0.01%	$33.34K
Xtx topco	34.05K	0.01%	$80.37K
Millennium management	2.70M	0.00%	$6.38M

Top Buyers

Holder	Shares	% Assets	Change
Toronto dominion bank	750.00K	0.00%	750.00K
Ubs group	89.51K	-	89.51K
Group one trading	52.64K	0.00%	52.64K
Xtx topco	34.05K	0.01%	34.05K
Susquehanna group, llp	33.09K	-	33.09K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	-	-	-4.05M
Orbimed advisors	-	-	-2.00M
Nantahala capital management	-	-	-1.45M
Goldman sachs group	-	-	-942.41K
Rtw investments, lp	2.51M	0.09%	-750.00K

New Positions

Holder	Shares	% Assets	Change	Value
Toronto dominion bank	750.00K	0.00%	750.00K	$1.77M
Ubs group	89.51K	-	89.51K	$211.23K
Group one trading	52.64K	0.00%	52.64K	$124.22M
Xtx topco	34.05K	0.01%	34.05K	$80.37K
Susquehanna group, llp	33.09K	-	33.09K	$78.10K

Sold Out

Holder	Change
Qube research	-194.00
Ica group wealth management	-200.00
Royal bank of canada	-800.00
Citadel advisors	-3.50K
Advisor group	-7.43K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	48	-4.00%	11,814,084	-51.88%	17	1.30%	21	-12.50%	13	-7.14%
Dec 31, 2024	49	16.67%	24,552,980	-14.38%	37	1.98%	24	71.43%	14	75.00%
Sep 30, 2024	41	-	28,647,040	-5.08%	43	1.20%	13	-	8	33.33%
Jun 30, 2024	41	-6.82%	30,178,631	-3.74%	60	1.13%	13	-48.00%	6	20.00%
Mar 31, 2024	44	4.76%	31,351,699	76.28%	72	4.26%	25	56.25%	5	-50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Simplify Propel Opportunities ETF	850.00K	1.59%	-
Biotech Growth Ord	474.28K	0.89%	-333.41K
BlackRock Credit Strategies Instl	231.56K	0.43%	-29.79K
LUNIS Biotech Growth Opp Fd I a	26.90K	0.05%	-
WEALTHGATE Biotech Fund Inst	26.90K	0.05%	26.90K
Fidelity Nasdaq Composite Index	19.87K	0.04%	-
SPDR® S&P® International Small Cap ETF	18.54K	0.03%	-
Dimensional Global Core Equity USD Acc	5.87K	0.01%	-
Dimensional Global Small Coms USD Acc	5.02K	0.01%	5.00
Dimensional World Equity GBP Acc	3.65K	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 01, 2022	Bharucha David	Chief Medical Officer	Buy	$14.58K
Dec 05, 2022	Bharucha David	Chief Medical Officer	Buy	$32.83K
Oct 19, 2022	Wills Robert James	-	Buy	$73.95K
Oct 20, 2022	Pasternak Richard C	-	Buy	$52.00K
Oct 20, 2022	Liebert Debra K.	-	Buy	$52.90K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q3	-	-
2023 Q2	-	-
2023 Q1	-	-

MIST Ownership FAQ

Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals shareholders are primarily institutional investors at 17.82%, followed by 4.71% insiders and 77.47% retail investors. The average institutional ownership in Milestone Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Milestone Pharmaceuticals falls below.

Who owns the most shares of Milestone Pharmaceuticals?

Milestone Pharmaceuticals’s largest shareholders are Blackrock (4.97M shares, 9.91%), Millennium management (2.7M shares, 4.08%), and Alta fundamental advisers (2.66M shares, 4.02%). Together, they hold 18.01% of Milestone Pharmaceuticals’s total shares outstanding.

Does Blackrock own Milestone Pharmaceuticals?

Yes, BlackRock owns 9.91% of Milestone Pharmaceuticals, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.56M$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 12.68% of its assets in 1.03M Milestone Pharmaceuticals shares, valued at 2.42M$.

Who is the top mutual fund holder of Milestone Pharmaceuticals shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Milestone Pharmaceuticals shares, with 1.59% of its total shares outstanding invested in 850K Milestone Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools